| Fungal identification using molecular tools: a primer for the natural products research community HA Raja, AN Miller, CJ Pearce, NH Oberlies Journal of natural products 80 (3), 756-770, 2017 | 950 | 2017 |
| Camptothecin and taxol: historic achievements in natural products research NH Oberlies, DJ Kroll Journal of natural products 67 (2), 129-135, 2004 | 541 | 2004 |
| Recent advances in annonaceous acetogenins L Zeng, Q Ye, NH Oberlies, G Shi, ZM Gu, K He, JL McLaughlin Natural Product Reports 13 (4), 275-306, 1996 | 441 | 1996 |
| Identification of hepatoprotective flavonolignans from silymarin SJ Polyak, C Morishima, V Lohmann, S Pal, DYW Lee, Y Liu, TN Graf, ... Proceedings of the national academy of sciences 107 (13), 5995-5999, 2010 | 393 | 2010 |
| Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro MT Morgan, Y Nakanishi, DJ Kroll, AP Griset, MA Carnahan, M Wathier, ... Cancer research 66 (24), 11913-11921, 2006 | 391 | 2006 |
| Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies DJ Kroll, HS Shaw, NH Oberlies Integrative cancer therapies 6 (2), 110-119, 2007 | 372 | 2007 |
| Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma KM VanderMolen, W McCulloch, CJ Pearce, NH Oberlies The Journal of antibiotics 64 (8), 525-531, 2011 | 358 | 2011 |
| Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells PR Davis-Searles, Y Nakanishi, NC Kim, TN Graf, NH Oberlies, MC Wani, ... Cancer research 65 (10), 4448-4457, 2005 | 315 | 2005 |
| Multiple effects of silymarin on the hepatitis C virus lifecycle J Wagoner, A Negash, OJ Kane, LE Martinez, Y Nahmias, N Bourne, ... Hepatology 51 (6), 1912-1921, 2010 | 296 | 2010 |
| Structure− Activity relationships of diverse annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) Cells NH Oberlies, C Chang, JL McLaughlin Journal of Medicinal Chemistry 40 (13), 2102-2106, 1997 | 282 | 1997 |
| Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes DJ Morré, R de Cabo, C Farley, NH Oberlies, JL McLaughlin Life Sciences 56 (5), 343-348, 1994 | 267 | 1994 |
| The MLL1-H3K4me3 axis-mediated PD-L1 expression and pancreatic cancer immune evasion C Lu, AV Paschall, H Shi, N Savage, JL Waller, ME Sabbatini, ... JNCI: journal of the National Cancer Institute 109 (6), djw283, 2017 | 223 | 2017 |
| Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite CR Strader, CJ Pearce, NH Oberlies Journal of natural products 74 (4), 900-907, 2011 | 222 | 2011 |
| Antioxidant activity and total phenolic content of aqueous and methanolic extracts of Jordanian plants: an ICBG project FQ Alali, K Tawaha, T El-Elimat, M Syouf, M El-Fayad, K Abulaila, ... Natural Product Research 21 (12), 1121-1131, 2007 | 220 | 2007 |
| Novel strategies for the discovery of plant-derived anticancer agents A Kinghorn, N Farnsworth, D Soejarto, G Cordell, S Swanson, J Pezzuto, ... Pharmaceutical Biology 41 (sup1), 53-67, 2003 | 212 | 2003 |
| The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells NH Oberlies, VL Croy, ML Harrison, JL McLaughlin Cancer letters 115 (1), 73-79, 1997 | 211 | 1997 |
| Fungal Planet description sheets: 716–784 PW Crous, MJ Wingfield, TI Burgess, GESJ Hardy, J Gené, J Guarro, ... Persoonia: Molecular Phylogeny and Evolution of Fungi 40, 240, 2018 | 210 | 2018 |
| High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products T El-Elimat, M Figueroa, BM Ehrmann, NB Cech, CJ Pearce, NH Oberlies Journal of natural products 76 (9), 1709-1716, 2013 | 193 | 2013 |
| Mechanisms underlying food–drug interactions: inhibition of intestinal metabolism and transport CS Won, NH Oberlies, MF Paine Pharmacology & therapeutics 136 (2), 186-201, 2012 | 190 | 2012 |
| Synergy-Directed Fractionation of Botanical Medicines: A Case Study with Goldenseal (Hydrastis canadensis) HA Junio, AA Sy-Cordero, KA Ettefagh, JT Burns, KT Micko, TN Graf, ... Journal of natural products 74 (7), 1621-1629, 2011 | 190 | 2011 |
Huzefa A. RajaUniversity of North Carolina at Greensboro在 uncg.edu 的电子邮件经过验证
